ALEC Stock Forecast: Alector, Inc. Price Predictions for 2026-2027

Last close, 20 Nov 2026
$2.34
+1.52% on the day

The 8 Wall Street analysts covering Alector, Inc. hold a median 12-month price target of $4.5 — +92.7% from the last close. Ticker Nerd's systematic factor model, run across ~4,300 US stocks, ranks it 94 of 100 as at 21 Nov 2026 — among the strongest tenth. Here, the model and the Street point the same way.

Market cap
$342.4M
Ticker Nerd rank
94/ 100
Median analyst target
$4.50
Analysts covering
8
Revenue$3.3M−57.8% y/y
Operating income−$24.4M
Net income−$23.0M
Free cash flow−$34.2M
Quarterly, 8 quarters to 30 June 2026 · latest quarter's figure shown
Total return, dividends reinvested
1W
−8.1%
1M
+18.5%
YTD
+49.7%
1Y
+94.6%
From 52W high
−14.2%
From 52W low
+104.8%
$1.14
$2.72
52-week range, adjusted closes · the dot is the last close
Ticker Nerd rank

One number for the whole business

Consensus tells you what everyone already believes. The model scores Alector, Inc. on its factor families — the same systematic rank behind the Ticker Nerd portfolio.

Where the model ranks itAs at 21 Nov 2026
94/ 100

Percentile across ~4,300 US stocks on Ticker Nerd’s systematic factor model. Higher is better. How the model is built and tested

Growth
99
Value
93
Revisions
89
Quality
75
Issuance
73
Momentum
63
Accruals
32
Volatility
30

Growth (99): Sales and profits are climbing, and climbing faster than before.

Volatility (30): The share price moves around a lot.

Built and run by Aslam Ghouse, an ex-Goldman Sachs systematic trader with 15+ years in markets.

Wall Street

ALEC stock forecast 2026-2027: analyst price targets & predictions

The bullish and bearish analyst opinions on ALEC, reported as data — targets and ratings, the market's view beside the model's.

Share price and the analyst range, 12 monthsAdjusted close, US dollars
$0.00$2.00$4.00$6.00$8.00Jan 26Apr 26Jul 26Oct 26ALECHigh $8.00Median $4.50Low $1.00

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Data provided by Twelve Data

What Wall Street says8 analysts
4
Buy
2
Hold
2
Sell
$1.00
Low
$4.50
Median
$8.00
High

The green dot is the last close — the median target sits +92.7% from it.

Recent analyst actionsNewest first

Of the 20 most recent actions, 3 moved their price target up and 1 moved it down.

DateFirmActionRatingTarget
13 Nov 2026Wells FargoInitiatesOverweight$7.00
15 Oct 2026HC Wainwright & Co.MaintainsBuy$5.00 → $8.00
14 Oct 2026HC Wainwright & Co.MaintainsBuy$5.00 → $8.00
6 Oct 2026Morgan StanleyMaintainsUnderweight$2.00 → $3.00
15 Apr 2026Cantor FitzgeraldUpgradeOverweight—
10 Mar 2026BTIGUpgradeBuy—
22 Oct 2025BTIGDowngradeNeutral—
22 Oct 2025Cantor FitzgeraldDowngradeNeutral—
22 Oct 2025HC Wainwright & Co.MaintainsBuy—
22 Oct 2025TD CowenDowngradeHold—
22 Oct 2025William BlairDowngradeMarket Perform—
25 Sept 2025BTIGReiteratesBuy—
28 July 2025MizuhoUpgradeOutperform—
9 May 2025HC Wainwright & Co.MaintainsBuy—
7 Mar 2025Morgan StanleyAssumesUnderweight$3.00 → $1.50
27 Feb 2025HC Wainwright & Co.ReiteratesBuy—
16 Dec 2024StifelDowngradeHold—
26 Nov 2024BTIGMaintainsBuy—
26 Nov 2024Cantor FitzgeraldReiteratesOverweight—
26 Nov 2024Morgan StanleyDowngradeUnderweight—

Price targets and ratings are third-party analyst estimates, reported here as data. They are not Ticker Nerd forecasts, and they are frequently wrong.

Wall Street targets run 12 to 18 months out. No analyst publishes a 2030 price target for ALEC.

Market Radar

This page is one stock. Monday covers all of them.

ALEC appears in the Radar on the weeks it earns a place.

  • Market Radar, every Monday: the week's biggest rank moves across ~4,300 US stocks, and the reason for each.
  • The AI build-out map, free: every AI company we track on one page, with the model's Top picks in all four parts.

Free. Unsubscribe any time. Privacy

The AI build-out map
PDF
  • AI cloud capacity

    MSFTAMZNGOOGLORCL

  • AI chips

    NVDAAVGOAMDMU

  • AI networking and servers

    ANETDELLLITECRDO

  • Data centre power

    VRTCEGGEVVST

Performance

ALEC vs the S&P 500

Both lines are total return — dividends reinvested — so the comparison is honest on both sides.

Over the twelve months to 20 Nov 2026, Alector, Inc. returned +94.6% against +6.9% for the S&P 500, dividends included.

ALEC vs S&P 500, last 12 monthsTotal return, rebased to 100
100150200Jan 26Apr 26Jul 26Oct 26ALECS&P 500

Download this chart as an image — free to reuse; link this page as the source.

Data provided by Twelve Data

Estimates

ALEC analyst estimate revisions

Not the forecast itself — the direction analysts are revising it. Revision direction is one of the model's factor families.

Which way the estimates are movingThis fiscal year
Analysts raising
2
Analysts cutting
0
Fundamentals

Financials

A margin means little on its own. Each bar marks where the figure sits across the whole US universe we score.

Valuation
Trailing P/E
6.5×

Cheaper than 83% of US stocks

Price / sales
2.1×

Cheaper than 48% of US stocks

Price / book
—
EV / EBITDA
5.3×

Cheaper than 81% of US stocks

Growth & margins
Revenue growth (YoY)
—
Earnings growth (YoY)
—
Gross margin
—
Operating margin
21.8%

Higher than 81% of US stocks

Net margin
—
Returns & dividend
Return on equity
—
Return on assets
9.5%

Higher than 91% of US stocks

Dividend yield
—

Bars mark the percentile across the ~4,300 US stocks Ticker Nerd covers, among those reporting the figure.

Statistics

Key statistics

The headline figures, each with its date. Every row carries its own link — cite it straight from here.

  • Alector, Inc. has a market value of $342.4M and an enterprise value of $224.7M.

  • Revenue in the twelve months to 30 June 2026: $13.9M. The latest quarter shrank 57.8% year on year.

  • Net income over the same four quarters: −$117.9M, a −850.1% net margin.

  • Diluted earnings per share, trailing twelve months: −$1.10.

  • Free cash flow in the twelve months to 30 June 2026: −$158.4M.

  • Shares outstanding: 111.7M.

  • Trailing P/E: 6.5×.

  • Alector, Inc. employs 103 people — $135K of revenue per employee.

Statement figures: company filings via Twelve Data, four quarters to 30 June 2026 · market figures as at 20 Nov 2026

Data provided by Twelve Data

Peers

ALEC and its peers

The nearest names by industry and size, scored by the same model — like for like.

Its peer group, ranked by the same modelBiotechnology
CompanyMarket capTKN rank
ALECAlector, Inc.$342.4M94
YDESYD Bio Ltd.$342.2M3
LYELLyell Immunopharma, Inc.$338.2M80
CTNMContineum Therapeutics, Inc.$336.4M32
PBYIPuma Biotechnology, Inc.$358.8M98
ASPEAspen Neuroscience, Inc.$361.2M0
LRMRLarimar Therapeutics, Inc.$331.6M29

Take a look at ALEC’s peer groups, ranked by the model: healthcare stocks · biotech stocks.

Look up any of the roughly 4,300 stocks we score.

The rank is the raw material. Whether the rules would actually own Alector, Inc. — and when they’d sell — is the membership. See the Ticker Nerd 20 →

FAQ

Questions about ALEC

What is the ALEC stock price forecast for 2026-2027?

The 8 Wall Street analysts covering Alector, Inc. have a median 12-month price target of $4.5, with estimates ranging from $1 to $8. These are third-party analyst estimates, not Ticker Nerd forecasts, and they are frequently wrong.

Is ALEC stock a buy right now?

Of the 8 analysts covering Alector, Inc., 4 rate it a Buy, 2 a Hold and 2 a Sell. Ticker Nerd's systematic factor model ranks Alector, Inc. 94 out of 100 across roughly 4,300 US stocks as at 21 Nov 2026. None of this is personal advice — it does not consider your circumstances.

How does Ticker Nerd's model rank ALEC?

As at 21 Nov 2026, Alector, Inc. ranks 94 out of 100 on Ticker Nerd's systematic factor model — a percentile across roughly 4,300 US stocks, built from its factor families. Its strongest factor family is Growth (99 of 100).

Will ALEC stock go up?

No one can know that. What the data says: the median 12-month target from 8 analysts implies +92.7% from the last close, and Ticker Nerd's factor model ranks Alector, Inc. 94 out of 100 as at 21 Nov 2026. Analyst targets are third-party estimates and frequently wrong; none of this is personal advice.

What is the ALEC stock forecast for 2030?

No analyst covering Alector, Inc. publishes a 2030 price target — Wall Street targets run 12 to 18 months out. Sites quoting a 2030 price for ALEC are extrapolating price history, which says nothing about the business. The furthest attributed numbers are the current analyst targets: $1 to $8 over the next 12 months.

How has ALEC stock performed over the past year?

Alector, Inc. returned +94.6% over the 12 months to 20 Nov 2026, with dividends reinvested. Past performance does not indicate future returns.

What does Alector, Inc. do?

Alector Inc. is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. Alector Inc. applies its immuno-neurology platform to target the immune dysfunction and protein-related pathology associated with conditions such as Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia.

Company

About Alector, Inc.

Alector Inc. is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. Alector Inc. applies its immuno-neurology platform to target the immune dysfunction and protein-related pathology associated with conditions such as Alzheimer’s disease, Parkinson’s disease, and frontotemporal dementia. The company’s current portfolio includes monoclonal antibody and other biologic programs designed to restore healthy immune function in the brain, supported by biomarker-guided clinical development. It also advances Alector Brain Carrier, a proprietary blood-brain barrier platform intended to improve therapeutic delivery to the central nervous system. Headquartered in South San Francisco, California, Alector Inc. operates as a research-driven biopharmaceutical company with a focus on translating genetics, immunology, and neuroscience into treatments for severe brain disorders.

CEO Dr. Arnon Rosenthal Ph.D. · 103 employees · United States · https://www.alector.com